LPCN
Lipocine Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Last price
2.06
▼ 0.03 (1.44%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
2.09
Prev close
2.09
Day high
2.11
Day low
2.06
Volume
17.78K
Market cap
$17.23M
P/E (TTM)
—
52W range
1.81 – 12.37
Day trading desk
Gap from prior close
+0.00%
Prior close 2.09
VWAP
2.10
-1.68% from price
Relative volume
0.27×
Quiet session
Session range
2.43%
2.06 – 2.11
Position in range
0%
Near session low
ATR (14D)
0.11
5.26% of price
Prior day high
2.13
PDH
Prior day low
2.05
PDL
Bid / ask spread
—
Quote not published
Session volume
17.78K
Avg 66.22K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.95%
+0.4%
1M
-4.57%
-8.3%
3M
-5.86%
-9.0%
6M
-78.67%
-89.7%
YTD
-73.97%
-86.3%
1Y
-31.25%
-51.2%
3Y
-58.12%
-132.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LPCN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
371.57K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Apr 7, 26 | HIGUCHI JOHN W Director |
BUY | 40.00K | $81.20K | Direct |
| Apr 6, 26 | HIGUCHI JOHN W Director |
BUY | 123.00K | $252.15K | Direct |
| Apr 6, 26 | PATEL MAHESH V Chief Executive Officer |
BUY | 25.00K | $50.75K | Direct |
| Apr 2, 26 | PATEL MAHESH V Chief Executive Officer |
BUY | 25.00K | $231.25K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
HIGUCHI JOHN W |
Director | 203.80K | Purchase |
PATEL MAHESH V |
Chief Executive Officer | 160.68K | Purchase |
Fundamentals
Market cap$17.23M
Enterprise value$-5.78M
Revenue (TTM)$1.57M
Gross profit$1.57M
EBITDA$-12.51M
Net income$-11.85M
EPS (TTM)$-1.85
Free cash flow$-6.94M
Total cash$23.27M
Total debt$257.81K
Book value / share$2.64
Shares outstanding8.24M
Float6.55M
Short % of float1.37%
Dividend yield—
Beta (5Y)0.46
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.69
PEG ratio—
Price / sales—
Price / book0.79
EV / revenue-3.68
EV / EBITDA0.46
Gross margin100.00%
Operating margin-1495.14%
Profit margin0.00%
Return on equity-60.94%
Return on assets-37.04%
Debt / equity1.18
Current ratio11.48
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.98M | $11.20M | -$2.85M | $500.00K | -82.3% |
| Operating revenue | $1.98M | $11.20M | -$2.85M | $500.00K | -82.3% |
| Cost of revenue | $8.58M | $7.35M | $10.18M | $8.56M | +16.8% |
| Gross profit | -$6.61M | $3.85M | -$13.03M | -$8.06M | -271.8% |
| Selling, general & admin | $3.76M | $5.00M | $4.90M | $4.06M | -24.7% |
| Total operating expense | $3.76M | $5.00M | $4.90M | $4.06M | -24.7% |
| Operating income | -$10.37M | -$1.16M | -$17.93M | -$12.12M | -797.9% |
| Net interest income | $744.07K | $1.15M | $1.37M | $545.48K | -35.1% |
| Pre-tax income | -$9.63M | $9.03K | -$16.35M | -$10.76M | -106,679.3% |
| Tax provision | $200 | $681 | $755 | $681 | -70.6% |
| Net income | -$9.63M | $8.35K | -$16.35M | -$10.76M | -115,371.9% |
| Net income to common | -$9.63M | $8.35K | -$16.35M | -$10.76M | -115,371.9% |
| Basic EPS | -1.77 | 0.00 | -3.10 | -2.04 | — |
| Diluted EPS | -1.77 | 0.00 | -3.14 | -2.21 | — |
| EBIT | -$10.37M | -$1.16M | -$17.93M | -$10.73M | -797.9% |
| EBITDA | -$10.31M | -$1.11M | -$17.90M | -$10.72M | -825.6% |
| Basic shares | 5.45M | 5.34M | 5.27M | 5.20M | +2.1% |
| Diluted shares | 5.71M | 5.42M | 5.27M | 5.23M | +5.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.21M | $6.21M | $4.77M | $3.15M | — | -16.1% |
| Cash & short-term investments | $14.93M | $21.63M | $22.04M | $32.53M | — | -31.0% |
| Total current assets | $16.88M | $22.32M | $22.86M | $34.14M | — | -24.4% |
| Property, plant & equipment | $104.29K | $165.07K | $116.09K | $131.59K | — | -36.8% |
| Total assets | $17.01M | $22.51M | $23.00M | $37.54M | — | -24.5% |
| Total current liabilities | $2.53M | $1.51M | $2.63M | $1.68M | — | +67.1% |
| Current debt | — | — | — | — | $2.31M | — |
| Total debt | — | — | — | — | $2.31M | — |
| Total liabilities | $2.53M | $1.51M | $2.63M | $1.91M | — | +67.1% |
| Retained earnings | -$209.40M | -$199.77M | -$199.78M | -$183.43M | — | -4.8% |
| Shareholder equity | $14.48M | $21.00M | $20.37M | $35.63M | — | -31.1% |
| Working capital | $14.35M | $20.81M | $20.23M | $32.46M | — | -31.0% |
| Net tangible assets | $14.48M | $21.00M | $20.37M | $35.63M | — | -31.1% |
| Shares issued | 6.16M | 5.35M | 5.32M | 5.21M | — | +15.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$9.63M | $8.35K | -$16.35M | -$10.76M | — | -115,371.9% |
| Depreciation & amortisation | $60.78K | $41.11K | $28.66K | $9.45K | — | +47.9% |
| Stock-based compensation | $242.50K | $408.55K | $654.44K | $636.14K | — | -40.6% |
| Change in working capital | -$243.56K | -$964.21K | $2.01M | -$923.63K | — | +74.7% |
| Operating cash flow | -$9.76M | -$1.22M | -$11.87M | -$11.97M | — | -699.3% |
| Capital expenditure | — | -$90.09K | -$13.17K | -$133.83K | -$7.59K | — |
| Investing cash flow | $5.89M | $2.45M | $13.08M | $14.29M | — | +140.8% |
| Share buybacks | — | — | — | -$21.70K | — | — |
| Financing cash flow | $2.87M | $209.34K | $404.57K | -$2.13M | — | +1,270.8% |
| Free cash flow | -$9.76M | -$1.31M | -$11.88M | -$12.10M | — | -644.3% |
| End cash position | $5.21M | $6.21M | $4.77M | $3.15M | — | -16.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $190.10K | $119.40K | $1.15M | $114.57K | $622.85K | — | +59.2% |
| Operating revenue | $190.10K | $119.40K | $1.15M | $114.57K | $622.85K | — | +59.2% |
| Cost of revenue | $2.04M | — | — | — | $2.14M | — | — |
| Gross profit | -$1.85M | — | — | — | -$1.51M | — | — |
| Research & development | — | $2.76M | — | $2.71M | — | $1.06M | — |
| Selling, general & admin | $990.96K | $1.20M | $983.39K | $767.84K | $890.43K | — | -17.7% |
| Total operating expense | $990.96K | $3.97M | -$4.92M | $3.48M | $890.43K | — | -75.0% |
| Operating income | -$2.84M | -$3.85M | -$2.52M | -$3.36M | -$2.40M | — | +26.2% |
| Net interest income | $219.85K | $177.57K | $145.72K | $174.21K | $198.64K | — | +23.8% |
| Pre-tax income | -$2.62M | -$3.67M | -$2.37M | -$3.19M | -$2.21M | — | +28.6% |
| Tax provision | $200 | $0 | $0 | $0 | $0 | — | — |
| Net income | -$2.62M | -$3.67M | -$2.37M | -$3.19M | -$2.21M | — | +28.6% |
| Net income to common | -$2.62M | -$3.67M | -$2.37M | -$3.19M | -$2.21M | — | +28.6% |
| Basic EPS | -0.32 | -0.54 | — | -0.59 | -0.41 | -0.35 | +40.7% |
| Diluted EPS | -0.32 | -0.54 | — | -0.59 | -0.41 | -0.35 | +40.7% |
| EBIT | -$2.84M | -$3.85M | -$2.52M | -$3.36M | -$2.40M | — | +26.2% |
| EBITDA | -$2.83M | -$3.83M | -$2.50M | -$3.35M | -$2.39M | — | +26.3% |
| Basic shares | 8.22M | 6.80M | — | 5.41M | 5.35M | 5.35M | +20.9% |
| Diluted shares | 8.22M | 6.80M | — | 5.41M | 5.35M | 5.35M | +20.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.98M | $5.02M | $5.21M | $3.90M | $6.04M | -0.7% |
| Cash & short-term investments | $23.27M | $24.73M | $14.93M | $15.13M | $17.94M | -5.9% |
| Total current assets | $23.74M | $25.24M | $16.88M | $15.93M | $18.42M | -6.0% |
| Property, plant & equipment | $74.83K | $89.48K | $104.29K | $119.27K | $133.40K | -16.4% |
| Total assets | $23.84M | $25.36M | $17.01M | $16.07M | $18.58M | -6.0% |
| Total current liabilities | $2.07M | $2.53M | $2.53M | $1.93M | $1.45M | -18.2% |
| Total liabilities | $2.07M | $2.53M | $2.53M | $1.93M | $1.45M | -18.2% |
| Retained earnings | -$215.69M | -$213.07M | -$209.40M | -$207.03M | -$203.84M | -1.2% |
| Shareholder equity | $21.77M | $22.83M | $14.48M | $14.14M | $17.13M | -4.7% |
| Working capital | $21.67M | $22.72M | $14.35M | $14.00M | $16.97M | -4.6% |
| Net tangible assets | $21.77M | $22.83M | $14.48M | $14.14M | $17.13M | -4.7% |
| Shares issued | 8.24M | 7.48M | 6.16M | 5.42M | 5.35M | +10.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$2.62M | -$3.67M | -$2.37M | -$3.19M | -$2.21M | — | +28.6% |
| Depreciation & amortisation | $14.65K | $14.81K | $14.98K | $14.12K | $16.11K | — | -1.1% |
| Stock-based compensation | $58.15K | $65.40K | $53.03K | $53.26K | $65.20K | — | -11.1% |
| Change in working capital | -$414.19K | $1.43M | -$551.03K | $167.64K | $272.58K | — | -128.9% |
| Operating cash flow | -$3.03M | -$2.26M | -$2.92M | -$2.99M | -$1.89M | — | -34.2% |
| Capital expenditure | — | — | — | — | — | -$10.02K | — |
| Investing cash flow | $1.48M | -$9.90M | $1.57M | $701.45K | $4.50M | — | +115.0% |
| Financing cash flow | $1.51M | $11.97M | $2.65M | $141.33K | $75.62K | — | -87.4% |
| Free cash flow | -$3.03M | -$2.26M | -$2.92M | -$2.99M | -$1.89M | — | -34.2% |
| End cash position | $4.98M | $5.02M | $5.21M | $3.90M | $6.04M | — | -0.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.40 | -0.32 | +20.0% |
| Mar 2026 | -0.49 | -0.54 | -11.3% |
| Dec 2025 | -0.61 | -0.42 | +31.1% |
| Sep 2025 | -0.54 | -0.59 | -9.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.32 | 1 | $219.00K | +91.2% |
| Next quarter | -0.40 | 1 | $225.00K | -80.4% |
| Current year | -1.55 | 1 | $753.50K | -61.9% |
| Next year | -1.65 | 1 | $1.09M | +44.7% |
Analyst targets & ownership
Mean target$6.00
High target$6.00
Low target$6.00
Implied upside191.26%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 1
Hold1
Sell / Strong sell0 / 0
Held by insiders4.51%
Held by institutions36.19%
Institutions holding38
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
2.07
-0.68% from price
SMA 20
2.10
-0.45% from price
SMA 50
2.25
-7.01% from price
SMA 100
2.39
-13.65% from price
SMA 200
4.53
-53.86% from price
EMA 12
2.09
-1.33% from price
EMA 26
2.14
-3.60% from price
EMA 50
2.30
-10.44% from price
RSI (14)
44.1
Neutral
MACD (12,26,9)
-0.05
Hist 0.01
ATR (14)
0.11
5.18% of price
Realised vol 30D
32.6%
Annualised
Bollinger upper
2.17
20, 2σ
Bollinger lower
2.03
20, 2σ
50 / 200 cross
Death
2.25 vs 4.53
Trend bias
Below 200
-53.86%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.39
More volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
32.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-82.8%
Peak to trough
Max drawdown 5Y
-93.8%
Peak to trough
ATR 14
0.11
5.18% of price
Beta (reported)
0.46
5Y monthly, from filing
Short interest
Shares short
110.96K
Prior 141.72K
Change vs prior
-21.7%
Shorts covering
% of float
1.37%
Normal
% of shares out
1.35%
Against total outstanding
Days to cover
3.0
Liquid
Float
6.55M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 6, 26 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Jan 21, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 13, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 20, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 27, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 10, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 27, 23 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:17
Split dateMay 12, 2023
SEC filings
Corporate Changes & Voting Matters
8-K/A · 2026-08-21
Periodic Financial Reports
10-Q · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-08-03
Corporate Changes & Voting Matters
8-K · 2026-06-12
Offering Registrations
S-8 · 2026-06-09
Corporate Changes & Voting Matters
8-K · 2026-06-04
Corporate Changes & Voting Matters
8-K · 2026-05-26
Corporate Changes & Voting Matters
8-K · 2026-05-19
Headlines
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026
PR Newswire · 19d ago
Lipocine: Q2 Earnings Snapshot
Associated Press · 19d ago
Lipocine Appoints Michael J. Grissinger to Board of Directors
PR Newswire · 20d ago
Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154
PR Newswire · 80d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.